Company Profile

ProCrysta Biologix Inc
Profile last edited on: 3/21/14      CAGE: 5VNF9      UEI:

Business Identifier: Protein purification, crystallization and formulation
Year Founded
2008
First Award
2011
Latest Award
2012
Program Status
Inactive
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

12 Michigan Drive
Natick, MA 01760
   (508) 318-6515
   information@procrysta.com
   www.procrysta.com
Location: Single
Congr. District: 05
County: Middlesex

Public Profile

ProCrysta Biologix Inc specializes in the field of purification, crystallization and formulation of proteins using crystallization technology for the biotechnology and pharmaceutical industry. ProCrysta is developing crystallization as a suite of comprehensive, scalable, and proprietary methodologies that address the challenges of production, formulation and delivery of biopharmaceuticals. The firm’s innovative approach is focused on designing an effective protein purification methodology that uses selective crystallization of desired proteins directly from fermentation broth or cell culture broth. These transgenic sources will be able to provide highly pure protein without going through elaborative conventional protein purification steps. This method is more cost effective and will reduce the time needed to purify the desired protein

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2012 2 NIH $535,150
Project Title: Crystalline Endolysin Treatment For Tuberculosis In Tb/Hiv Co-Infected Patients

Key People / Management

  Bhami C Shenoy -- President

Company News

There are no news available.